Published on : Tuesday, October 24, 2017
ICCA Final preparations are underway as BestCities Global Alliance, visitBerlin – one of the Alliance’s partner destinations – and leading Professional Conference Organiser, Kenes Group, get ready to welcome delegates to their inaugural original event in Berlin. Senior level attendees from leading international pharma and biotech companies, academia and government institutions are expected at the Summit on Controversies in Precision Medicine (CPMed),
due to take place at the Ameron Hotel Abion Spreebogen Waterside, 13-15 November 2017.
The Summit is the first event following a landmark agreement signed by Kenes and BestCities, to initiate and manage original events in the 12 BestCities global locations. With a shared ambition to deliver high-level meetings for doctors, researchers, and specialists, not formally structured through existing associations, the events are a unique opportunity to study a specialised area of expertise, providing a valuable knowledge sharing and networking platform.
Under the leadership of Prof Dan Peer, Director of Tel Aviv University Cancer Biology Research Centre and Translational Medicine, CPMed will address the challenges in precision medicine head-on. Titled, “Where do we stand in drug development?”, the Summit will create a focused environment for quality and open scientific debate on the value and direction of the industry. With an interactive architecture, the event is designed to provide the participants with exciting opportunities to ignite solutions, network and innovate.
Work is already underway to initiate a number of future original events through the collaboration of BestCities, Kenes Group and high-profile opinion leaders from around the world, in key fields where there is a potential to create an original event.